Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,970 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis.
Izumi R, Hashimoto T, Kisanuki H, Ikuta K, Otsuru W, Asakawa S, Yamamoto S, Misumi K, Fujino T, Shinohara K, Matsushima S, Hosokawa K, Katsuki S, Mori T, Hashisako M, Tateishi Y, Iwasaki T, Oda Y, Kinugawa S, Abe K. Izumi R, et al. Among authors: oda y. Cardiooncology. 2024 Nov 21;10(1):82. doi: 10.1186/s40959-024-00288-0. Cardiooncology. 2024. PMID: 39574216 Free PMC article.
Effect of sampling face velocity on the ultrafine particle surface collection efficiency of a cellulose membrane filter and a cellulose-glass fiber filter for environmental airborne radioactivity monitoring.
Kiso M, Taoka M, Sampei A, Hashimoto H, Abe Y, Oda Y, Omori Y, Yamada R, Hosoda M, Kranrod C, Ishikawa T, Tokonami S. Kiso M, et al. Among authors: oda y. Radiat Prot Dosimetry. 2024 Nov 13;200(16-18):1671-1675. doi: 10.1093/rpd/ncae191. Radiat Prot Dosimetry. 2024. PMID: 39540486 Free PMC article.
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS).
Funauchi Y, Tsukushi S, Hiraga H, Sakamoto A, Kunisada T, Nagano A, Hiraoka K, Kikuta K, Yonemoto T, Ae K, Kawai A, Endo M, Sano Y, Machida R, Sekita T, Fukuda H, Oda Y, Ozaki T, Tanaka K; JCOG Bone Soft Tissue Tumor Study Group. Funauchi Y, et al. Among authors: oda y. Jpn J Clin Oncol. 2024 Nov 5:hyae160. doi: 10.1093/jjco/hyae160. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39500618
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Uraki R, Okazaki K, Minami R, Nagasaki Y, Nagashima M, Yoshida I, Sadamasu K, Yoshimura K, Ito M, Kiso M, Yamayoshi S, Imai M, Ikeda T, Sato K, Toyoda M, Ueno T, Inoue T, Tanaka Y, Kimura KT, Hashiguchi T, Sugita Y, Noda T, Morioka H, Kawaoka Y, Matsushita S; Genotype to Phenotype Japan (G2P-Japan) Consortium. Kuwata T, et al. EBioMedicine. 2024 Nov 1;110:105439. doi: 10.1016/j.ebiom.2024.105439. Online ahead of print. EBioMedicine. 2024. PMID: 39488016 Free PMC article.
2,970 results